Pulmotect Awarded $8.9 Million from The State of Texas
Funding from the Cancer Prevention and Research Institute of Texas will support development for Phase 2 Anti-Viral Trial and further development of PUL-042 HOUSTON, TEXAS , UNITED STATES, May 30, 2023 /EINPresswire.com/ -- Houston, TX (May 30, …